XML 31 R20.htm IDEA: XBRL DOCUMENT
v3.22.2.2

14. Restructuring Costs (Notes) | 3 Months Ended
--- | ---
Sep. 30, 2022
Restructuring Costs [Abstract] |
Restructuring and Related Activities Disclosure [Text Block] | RESTRUCTURING COSTS In February 2021, we announced our strategy-driven restructuring plan in furtherance of our ongoing program to improve operating performance. The restructuring plan primarily impacts our operations in EMEA and includes the elimination of certain positions, the consolidation of certain functions, and the relocation of certain manufacturing operations from EMEA to APAC. The restructuring plan is being implemented in phases and is expected to be substantially complete by mid-2023. The liability of $36.4 million as of September 30, 2022 was recorded in Accrued payroll and employee benefits in the condensed consolidated balance sheets. The amounts reflected in Cost of goods sold, Selling, general and administrative expense and Research and development expense for the three months ended September 30, 2022 were $1.3 million, $2.8 million and $0.5 million, respectively, in the condensed consolidated statements of income (loss). The amounts reflected in Cost of goods sold, Selling, general and administrative expense and Research and development expense for the nine months ended September 30, 2022 were $1.3 million, $3.0 million and $0.3 million, respectively, in the condensed consolidated statements of income (loss). The adjustments to expense recorded were primarily due to extension of termination dates for certain employees and for changes in the estimates of employee termination benefits. From February 2021 to September 30, 2022, total expenses were $69.0 million. The following table summarizes the activity of our European reorganization restructuring reserves (in millions):
|  | Life Science |  | Clinical Diagnostics |  | Total
Balances as of December 31, 2021: |  | $ | 5.2 |  |  | $ | 41.9 |  |  | $ | 47.1 |
Adjustment to expense |  | 1.2 |  |  | 3.4 |  |  | 4.6 |
Cash payments |  | (2.6) |  |  | (6.9) |  |  | (9.5) |
Foreign currency translation gains |  | (0.5) |  |  | (5.3) |  |  | (5.8) |
Balances as of September 30, 2022: |  | $ | 3.3 |  |  | $ | 33.1 |  |  | $ | 36.4 |

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(e)) -URI https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -URI https://asc.fasb.org/topic&trid=2175745 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (e) -URI https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RestructuringCostsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration